Biotechnology Analyst Karnauskas holds a group dinner meeting with Gilead Sciences (GILD) and Arcus Biosciences (RCUS) on January 10 at 6 pm hosted by Truist.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GILD:
- Hookipa Pharma achieves $5M milestone payment from Gilead
- Truist biotech analyst to hold an industry dinner meeting
- EVOQ to potentially receive $658.5M in Gilead collaboration on immunotherapies
- RBC downgrades Gilead, says drivers need time to play out
- Gilead downgraded to Sector Perform from Outperform at RBC Capital